Cambridge Therapeutics founder and chairman John Klein directs the innovative work of a Teaneck, New Jersey-based team dedicated to producing next-generation medical devices and health care products. Outside of his pursuits with Cambridge Therapeutics, he supports nonprofit organizations focused on health care, education, and the public good. John Klein also serves as a trustee with Hackensack Meridian Health Hospitals, a network that consistently receives high rankings for its quality of care.

In 2018, the local news outlet NJ.com amplified a report analyzing the safety of hospitals nationwide and noting how the medical facilities in New Jersey had ranked. The NJ.com article’s lead noted the good news that New Jersey’s hospitals as a group earned more top ratings for safety than the hospitals of any other state.

Thirty-eight of the 67 New Jersey hospitals surveyed – including eight facilities in the HMH network – received a grade of “A.”

Produced under the branding of the Leapfrog Hospital Safety Grade organization, the report was six years in the making, as an expert panel evaluated hospitals in terms of their ability to keep patients secure from infections, injuries, and staff errors.

Among the other recent accolades that HMH has received is a 2018-19 U.S. News & World Report ranking as one of the state’s two best hospitals overall.